Cargando…

De-novo hepatocellular carcinoma after pediatric living donor liver transplantation

De-novo malignancies carry an incidence ranging between 3%-26% after transplant and account for the second highest cause of post-transplant mortality behind cardiovascular disease. While the majority of de-novo malignancies after transplant usually consist of skin cancers, there has been an increasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torres-Landa, Samuel, Muñoz-Abraham, Armando Salim, Fortune, Brett E, Gurung, Ananta, Pollak, Jeffrey, Emre, Sukru H, Rodriguez-Davalos, Manuel I, Schilsky, Michael L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756726/ https://www.ncbi.nlm.nih.gov/pubmed/29359020 http://dx.doi.org/10.4254/wjh.v9.i36.1361

Ejemplares similares

A case report of de novo hepatocellular carcinoma after living donor liver transplantation
por: Yu, Songfeng, et al.
Publicado: (2013)

Preliminary Report of the ministry of health working group on standardization of living donor liver transplantation in Turkiye
por: Umman, Veysel, et al.
Publicado: (2022)

Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors?
por: Saidi, R. F., et al.
Publicado: (2013)

Living Donor Liver Transplantation for Patients with Hepatocellular Carcinoma
por: Akamatsu, Nobuhisa, et al.
Publicado: (2014)

Expansion of Patient Education Programming Regarding Live Donor Liver Transplantation via Virtual Group Encounters During the COVID-19 Pandemic
por: Joyce, Michael, et al.
Publicado: (2021)

Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience
por: dos Santos, José Pedro Fernandes, et al.
Publicado: (2021)

ABO-incompatible living-donor pediatric kidney transplantation in Japan
por: Aikawa, Atsushi, et al.
Publicado: (2014)

Donor sex and donor-recipient sex disparity do not affect hepatocellular carcinoma recurrence after living donor liver transplantation
por: Oh, Rak Kyun, et al.
Publicado: (2023)

Evaluating graft function in pediatric recipients for living donor renal transplantation: Is laparoscopic donor nephrectomy safe?
por: Mishra, Shashikant, et al.
Publicado: (2009)

Living Donor Versus Deceased Donor Pediatric Liver Transplantation: A Systematic Review and Meta-analysis
por: Barbetta, Arianna, et al.
Publicado: (2021)

Long‐Term Safety and Efficacy of Pure Laparoscopic Donor Hepatectomy in Pediatric Living Donor Liver Transplantation
por: Kim, Wan‐Joon, et al.
Publicado: (2020)

Optimal Sequencing of Deceased Donor and Live Donor Kidney Transplant Among Pediatric Patients With Kidney Failure
por: Kiberd, Bryce A., et al.
Publicado: (2022)

Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison
por: Sotiropoulos, Georgios C., et al.
Publicado: (2018)

The Effect of Pediatric Living Donor Liver Transplantation on Neurocognitive Outcomes in Children
por: Sun, Ying, et al.
Publicado: (2019)

Varicella Infection in an Immunized Pediatric Living Donor Liver-Transplant Recipient
por: Mehta, Vibha, et al.
Publicado: (2021)

Repeated-Measures Implication of Hepatocellular Carcinoma Biomarkers in Living Donor Liver Transplantation
por: Chiu, King-Wah, et al.
Publicado: (2015)

Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2021)

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
por: Lee, Okjoo, et al.
Publicado: (2022)

An Approach to Pediatric or Mentally Deficient Donors from a Bioethical Perspective: Considerations and Recommendations on Behalf of the Donor Research Team of the Turkish Society of Hematology (DART)
por: Keleş, Şükrü, et al.
Publicado: (2022)

Long-term Growth of Pediatric Patients Following Living-Donor Liver Transplantation
por: Park, Seong Jong, et al.
Publicado: (2005)

Long-term Outcomes of ABO-incompatible Pediatric Living Donor Liver Transplantation
por: Honda, Masaki, et al.
Publicado: (2018)

Pediatric living-donor liver transplantation using right posterior segment grafts
por: Qu, Xiaoye, et al.
Publicado: (2021)

Commentary: Evolution of pediatric living-donor lung transplant: Adaptation to unique environment
por: Adachi, Iki, et al.
Publicado: (2020)

The Impact of Hepatic Artery Thrombosis on the Outcome of Pediatric Living Donor Liver Transplantations
por: Stefanowicz, Marek, et al.
Publicado: (2023)

Safety and Tolerance of Donor-Derived Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation: The MYSTEP1 Study
por: Hartleif, Steffen, et al.
Publicado: (2017)

Peritoneal Recurrence of Initially Controlled Hepatocellular Carcinoma after Living Donor Liver Transplantation
por: Sadykov, Nariman, et al.
Publicado: (2015)

Optimal Tailored Screening Protocol after Living Donor Liver Transplantation for Hepatocellular Carcinoma
por: Park, Min-Su, et al.
Publicado: (2014)

Two cases of pulmonary metastasis after living donor liver transplantation for hepatocellular carcinoma
por: Khan, Mohammed Qaseem, et al.
Publicado: (2006)

Outcomes of Living Donor Liver Transplantation in Patients With a History of Ruptured Hepatocellular Carcinoma
por: Lee, Hwi Yeol, et al.
Publicado: (2021)

Superior Outcomes and Reduced Wait Times in Pediatric Recipients of Living Donor Liver Transplantation
por: Kehar, Mohit, et al.
Publicado: (2019)

Pediatric Living-Donor Liver Transplant Recipients without Transition After Reaching Adulthood
por: Nakanishi, Chikashi, et al.
Publicado: (2019)

Comparison of Cardioprotective Effects of Propofol versus Sevoflurane in Pediatric Living Donor Liver Transplantation
por: Weng, Yiqi, et al.
Publicado: (2020)

Outcomes After Living Donor Liver Transplantation in Pediatric Patients with Inherited Metabolic Diseases
por: Sanada, Yukihiro, et al.
Publicado: (2021)

Living donor liver transplantation in a pediatric patient with congenital absence of the portal vein
por: Namgoong, Jung-Man, et al.
Publicado: (2021)

Rex Shunt for Portal Vein Thrombosis After Pediatric Living Donor Liver Transplantation
por: Soejima, Yuji, et al.
Publicado: (2021)

Living donor liver transplantation for combined hepatocellular-cholangiocarcinoma: A case series of four patients
por: Ito, Takashi, et al.
Publicado: (2020)

Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma
por: Kim, Minjae, et al.
Publicado: (2021)

Analysis of Donor Motivations in Living Donor Liver Transplantation
por: Abdeldayem, Hesham, et al.
Publicado: (2014)

Utilization of single-use flexible ureterorenoscope for ex-vivo stone extraction in living kidney donors
por: Kiremit, Murat Can, et al.
Publicado: (2021)

Q-FISH Measurement of Hepatocyte Telomere Lengths in Donor Liver and Graft after Pediatric Living-Donor Liver Transplantation: Donor Age Affects Telomere Length Sustainability
por: Kawano, Youichi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1jn5r256i8j2sqm8af4sj8fjlq